Case Filed In CMM Court Infake Covid Medicines’ Case

Kanpur : Gangs which supplied fake medicines during the Covid second wave in Uttar Pradesh and Uttarakhand had been busted by the crime branch of UP Police last year. Now the lab reports have also confirmed that the medicines sold by such gangs were fake. Most of the drugs were antibiotics and pain relievers. The drug department had sent the samples for laboratory tests.

After sending the report to the government and the Kanpur district magistrate on behalf of the drugs department, a case was filed in the CMM court here on March 31.

To recall, the STF had arrested several people and seized 268 fake Remdesivir injections in Babupurwa locality of the city. After this the crime branch became active and the team led by the then ADCP Deepak Bhukar raided Uttarakhand and several cities, including Kanpur, Lucknow, Meerut, Aligarh and Hapur. During this period, there was a huge seizure of medicines, besides raw material for making medicines, packing machines, wrappers, etc. The drug department had sent the samples of these drugs to the laboratory for testing. Now after the investigation report, it came to fore that all these medicines were fake.

The drugs department filed a case on March 31 in the local Chief Metropolitan Magistrate (CMM) court after the medicines were found to be counterfeit.

“A case has been filed in connection with seizure of fake medicines during the second wave of Covid last year. Also, a final report with regard to its investigation has also been attached. An owner of a medicines warehouse- Manish, a resident of Lucknow (Ashiyana), was among those arrested. He used to produce and supply spurious medicines in the market along with his associates on a large scale,” said drug inspector Sandesh Kumar Maurya.

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert